Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juvista in Bilateral Reduction Mammaplasty
NCT00432328Phase 2Terminated
- Sponsor
- Renovo
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Hypertrophic Scar (HS) comparing Juvista with Placebo (2 arms). Primary endpoints: Investigator Scar Assessment, Patient Scar Assessment and 1 more. Started Oct 2006; status: terminated.
02
Drugs
avotermin
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT00432328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432328.